About 40% of drugs in the pipeline and 60% of drugs coming directly from synthesis or high throughput screening
are classified as poorly soluble. Consequently, they have bioavailability and/or delivery problems.
The mission:
PharmaSol provides solutions for overcoming the solubility and related bioavailability problems of poorly soluble
compounds. PharmaSol solutions are simple, cost-effective, regulatorily acceptable and cover lab to industrial
scale production. Focus areas are oral, dermal and intravenous delivery.
Nanocrystals
PharmaSol's expertise:
Pharmaceutical solutions to increase the Solubility of poorly soluble compounds.
(C)opyright 2004, PharmaSol GmbH. All rights reserved.
